Marco A. Zarbin

About

Marco A. Zarbin, MD, PhD, FACS has served as the Chair of the Institute of Ophthalmology and Visual Science at Rutgers-New Jersey Medical School for over 25 years. His extensive educational background includes an undergraduate degree from Dartmouth College and both MD and PhD degrees from Johns Hopkins University School of Medicine. Dr. Zarbin is considered an expert in his field, specializing in vitreoretinal surgery and research. He is recognized as a leading global expert, having refereed over 100 peer-reviewed publications and published nearly 120 books and chapters. His contributions include significant research and expertise in medical and surgical diseases of the retina, vitreous, and macula. Dr. Zarbin is actively involved in clinical practice, taking call 24/7 for ophthalmic trauma services at University Hospital in Newark, NJ, and the VA Hospital in East Orange, NJ. He has secured extensive funding for his institute through grants and endowments, and has received numerous honors, including the Honor Award from the American Society of Retina Specialists and recognition in the Retina Times. He is also set to receive the LuEsther Mertz Retinal Research Lectureship Award. Dr. Zarbin continues to educate and lead by example to his faculty, students, and staff.

Research topics

• Medicine
• Ophthalmology
• Internal medicine
• Surgery
• Environmental health
• Pediatrics
• Demography
• Oncology
• Immunology
• Pharmacology

Selected publications

• Angiopoietin/Tie2 signalling and its role in retinal and choroidal vascular diseases: a review of preclinical data

  Eye · 2021 · 233 citations

  Senior authorCorresponding

  The angopoietin/tyrosine kinase with immunoglobulin and epidermal growth factor homology domains (Ang/Tie) pathway is an emerging key regulator in vascular development and maintenance. Its relevance to clinicians and basic scientists as a potential therapeutic target in retinal and choroidal vascular diseases is highlighted by recent preclinical and clinical evidence. The Ang/Tie pathway plays an important role in the regulation of vascular stability, in angiogenesis under physiological and path…

  DOI

• Neovascular Age-Related Macular Degeneration: Therapeutic Management and New-Upcoming Approaches

  International Journal of Molecular Sciences · 2020 · 203 citations

  Senior authorCorresponding

  Age-related macular degeneration (AMD) constitutes a prevalent, chronic, and progressive retinal degenerative disease of the macula that affects elderly people and cause central vision impairment. Despite therapeutic advances in the management of neovascular AMD, none of the currently used treatments cures the disease or reverses its course. Medical treatment of neovascular AMD experienced a significant advance due to the introduction of vascular endothelial growth factor inhibitors (anti-VEGF),…

  DOI

• Recent Progress in Retinal Pigment Epithelium Cell-Based Therapy for Retinal Disease

  Stem Cells Translational Medicine · 2024-02-23 · 42 citations

  articleOpen accessSenior authorCorresponding

  Age-related macular degeneration and retinitis pigmentosa are degenerative retinal diseases that cause severe vision loss. Early clinical trials involving transplantation of retinal pigment epithelial cells and/or photoreceptors as a treatment for these conditions are underway. In this review, we summarize recent progress in the field of retinal pigment epithelium transplantation, including some pertinent clinical trial results as well as preclinical studies that address issues of transplant imm…

  PublisherOA PDFDOI

• Predictive factors of enucleation after open globe injuries

  Graefe s Archive for Clinical and Experimental Ophthalmology · 2020 · 29 citations

  DOI

• Recent Progress in Photoreceptor Cell-Based Therapy for Degenerative Retinal Disease

  Stem Cells Translational Medicine · 2024-02-28 · 20 citations

  articleOpen accessSenior authorCorresponding

  Age-related macular degeneration and retinitis pigmentosa are degenerative retinal diseases that cause severe vision loss. Early clinical trials involving transplantation of photoreceptors as treatment for these conditions are underway. In this review, we summarize recent progress in the field of photoreceptor transplantation, including some pertinent results regarding photoreceptor manufacture, photoreceptor transplantation, mechanisms of donor-host cell integration such as material transfer an…

  PublisherOA PDFDOI

Recent grants

• NIH Grant R01EY009750

  NIH · $3.1M · 2003

• Neural Stability after Retinal Detachment

  NIH · $2.0M · 2012–2018

Frequent coauthors

• Neelakshi Bhagat

  Toronto Metropolitan University

  519 shared

• Aditya Uppuluri

  Rutgers New Jersey Medical School

  144 shared

• Paul D. Langer

  Rutgers, The State University of New Jersey

  137 shared

• Maria Vittoria Cicinelli

  Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele

  98 shared

• Ilene K. Sugino

  Rutgers New Jersey Medical School

  95 shared

• Alain Bauza

  94 shared

• Francesco Bandello

  Vita-Salute San Raffaele University

  77 shared

• Rosangela Lattanzio

  Vita-Salute San Raffaele University

  53 shared

Education

• B.A.

  Dartmouth College

  1978

• M.D.

  Johns Hopkins University School of Medicine

  1984

• Ph.D.

  Johns Hopkins University School of Medicine

  1984

Awards & honors

• Honor Award from the American Society of Retina Specialists…
• LuEsther Mertz Retinal Research Lectureship Award (set to be…

Similar researchers at Rutgers University

• Joseph DeLucah-119
• Peter S. Hershh-59
• Mohammed H. Dastjerdih-37